The India pharmaceutical contract sales organizations market size was estimated at USD 309.8 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2030. Increasing pharmaceutical outsourcing trends, pharmaceutical industry complexity, and e... Read More »
December 2023The global tourette syndrome treatment market size was valued at USD 2.07 billion in 2022 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.96 % from 2023 to 2030. The ongoing research advancements, increased awareness and advocacy efforts, government initiatives, inno... Read More »
December 2023The global microneedle flu vaccine market size was valued at USD 1.4 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 6.20% from 2023 to 2030.The microneedle flu vaccine market is anticipated to experience significant growth due to the rising worldwide ... Read More »
December 2023The global scopolamine market size was valued at USD 385 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.75% from 2023 to 2030. The rising incidence of motion sickness and the increasing population of geriatrics are anticipated to boost the demand f... Read More »
December 2023The global antifungal drugs market size was estimated at USD 15.8 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 3.8% from 2024 to 2030. The growing prevalence of fungal infections such as aspergillosis and candidiasis is one of the key factors propel... Read More »
December 2023The global prostate cancer diagnostics market size was estimated at USD 8.56 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2030. Increasing prevalence of prostate cancer is a major factor contributing to the market growth. According ... Read More »
December 2023The global primary biliary cholangitis therapeutics market size was valued at USD 686.5 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2030. Primary biliary cholangitis (PBC) is an autoimmune liver disease that affects small bile duct... Read More »
December 2023The global non hodgkin lymphoma therapeutics market size was valued at USD 9.14 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.95% from 2023 to 2030. The non hodgkin lymphoma therapeutics market is anticipated to experience significant... Read More »
December 2023The global hairy cell leukemia market size was valued at USD 88.2 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.06% from 2023 to 2030.The increasing incidence of hairy cell leukemia, particularly in older adults, is a fundamental driver that drives ... Read More »
December 2023The global biliary stents market size was estimated at USD 140.96 million in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 5.0% from 2024 - 2030. The market is witnessing significant growth, largely attributed to the increasing prevalence of biliary disorders... Read More »
December 2023The global retinoblastoma treatment market size was valued at USD 2.42 billion in 2022 and is expected to grow at a CAGR of 4.26% over the forecast period. This is attributed to the rising incidence of retinoblastoma, growing advancements in medical technology, and increasing number of r... Read More »
December 2023The global psychedelic drugs market size was valued at USD 1,595.5 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 12.1% from 2023 to 2030. The increasing awareness of the significance of treating mental health and the growing prevalence of mental healt... Read More »
December 2023The global malignant glioma therapeutics market size was valued at USD 1.40 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 10.26% from 2023 to 2030. This is attributed to the rising incidence of brain tumor, the increasing number of research & deve... Read More »
December 2023The global point-of-care molecular diagnostics market size was estimated at USD 8.17 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 2.5% from 2024 to 2030. Increasing prevalence of chronic and infectious diseases and genetic disorders, such as Alzheime... Read More »
December 2023The global blood culture test market size was estimated at USD 5.92 billion in 2023 and is expected to growat a compound annual growth rate (CAGR) of 12.3% from 2024 to 2030. Increasing approval of novel products by regulatory bodies for bloodstream infection (BSI) diagnosis and increasi... Read More »
December 2023The global cancer immunotherapy market size was estimated at USD 125.69 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.3% from 2024 to 2030. Increasing prevalence of cancer is a major factor contributing to the market growth. According to the Americ... Read More »
December 2023The global anthrax treatment market size was valued at USD 361.4 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.95% from 2023 to 2030. The anthrax treatment market is anticipated to witness significant growth due to the rising number of novel and inn... Read More »
December 2023The U.S. tendon repair marke sizet was valued at USD 691.0 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2030. This can be attributed to the rising geriatric population, increasing demand for minimally invasive procedures, and the gr... Read More »
December 2023The global hearing loss disease treatment market size was valued at USD 13.62 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.25% from 2024 to 2030. Increasing prevalence, rising age-related sensorineural degeneration, and rising awareness among peopl... Read More »
December 2023The global endometrial cancer market size was valued at USD 25.10 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.69% from 2023 to 2030. This is attributed to the rising incidence of endometrial cancer, growing advancements in early detection & di... Read More »
December 2023